Monograph Eligibility To Include U.S. Rx-Only Drugs With Foreign OTC Data
This article was originally published in The Tan Sheet
Executive Summary
A drug marketed OTC in foreign countries but limited to Rx use in the U.S. could be considered for eligibility in the OTC monograph system under FDA's final rule on "material time, material extent" criteria, published in the Federal Register Jan. 23